PDL BioPharma (PDLI) Reports Resignation of Ernst & Young as Independent Registered Account Firm
Tweet Send to a Friend
PDL BioPharma (NASDAQ: PDLI) shares are slumping Wednesday after the company disclosed the following:On September 11, 2014, PDL BioPharma, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE